COMBINATION CANCER TREATMENTS UTILIZING SYNTHETIC OLIGONUCLEOTIDES AND EGFR-TKI INHIBITORS

• 收藏
• 分享

专利权人:

发明人:

Andreas BADER,Jane ZHAO,Kevin KELNAR

申请号：

US15298887

公开号：

US20170035797A1

申请日:

2016.10.20

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The disclosure provides methods and compositions for treating cancer cells, including cancer cells in a subject, whereby two or more therapeutic agents are used, one being an EGFR-TKI agent and the other being a synthetic oligonucleotide.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/